Maximus, Inc. (NYSE:MMS) Shares Purchased by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. lifted its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 75.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 84,352 shares of the health services provider's stock after acquiring an additional 36,396 shares during the quarter. Harbor Capital Advisors Inc. owned 0.15% of Maximus worth $5,752,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of the company. Norges Bank acquired a new stake in Maximus in the fourth quarter valued at approximately $71,443,000. SG Capital Management LLC purchased a new position in shares of Maximus during the 4th quarter valued at approximately $30,285,000. Federated Hermes Inc. grew its stake in Maximus by 74.8% in the 4th quarter. Federated Hermes Inc. now owns 882,953 shares of the health services provider's stock valued at $65,912,000 after acquiring an additional 377,705 shares during the period. Reinhart Partners LLC. grew its stake in Maximus by 65.4% in the 1st quarter. Reinhart Partners LLC. now owns 911,511 shares of the health services provider's stock valued at $62,156,000 after acquiring an additional 360,365 shares during the period. Finally, Squarepoint Ops LLC purchased a new stake in Maximus in the 4th quarter worth $22,661,000. 97.21% of the stock is owned by hedge funds and other institutional investors.

Maximus Price Performance

MMS stock traded down $1.30 during trading on Friday, hitting $69.66. The stock had a trading volume of 331,547 shares, compared to its average volume of 568,670. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97. The company's 50-day moving average price is $70.45 and its two-hundred day moving average price is $71.17. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The stock has a market capitalization of $3.93 billion, a P/E ratio of 14.98 and a beta of 0.62.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, topping the consensus estimate of $1.37 by $0.64. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The firm had revenue of $1.36 billion during the quarter, compared to analysts' expectations of $1.29 billion. During the same period in the previous year, the business earned $1.57 earnings per share. The firm's revenue for the quarter was up 1.0% on a year-over-year basis. As a group, research analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th were issued a $0.30 dividend. The ex-dividend date was Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.72%. Maximus's payout ratio is 23.86%.

Insiders Place Their Bets

In related news, Director Gayathri Rajan sold 7,913 shares of the stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $72.38, for a total value of $572,742.94. Following the completion of the sale, the director now owns 14,205 shares of the company's stock, valued at approximately $1,028,157.90. This trade represents a 35.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jan Madsen sold 2,439 shares of the company's stock in a transaction on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now owns 18,097 shares of the company's stock, valued at approximately $1,225,347.87. The trade was a 11.88% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.60% of the company's stock.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a research report on Thursday, May 15th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.